BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3902240)

  • 1. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias.
    Michelson EL; McGeehin FC; Levin BK
    Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic studies of procainamide given intermittently intravenously in patients with severe ventricular arrhytmias.
    Wierzchowiecki M; Jasiński K; Trojanowicz R; Ochotny R; Tomaszkiewicz T
    Cor Vasa; 1978; 20(3):176-83. PubMed ID: 688755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination drug therapy for ventricular arrhythmias.
    Krichbaum DW
    Clin Pharm; 1988 Nov; 7(11):808-19. PubMed ID: 3058377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procain amide and phenytoin as anti-arrhythmia agents, some dosage principles].
    Karlsson E
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1198-200. PubMed ID: 4839996
    [No Abstract]   [Full Text] [Related]  

  • 9. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J
    Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic and clinical control of antiarrhythmic drugs.
    Bigger JT
    Am J Med; 1975 Apr; 58(4):479-88. PubMed ID: 1092163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
    Kalin ML; Babich MF; Klinke WP; Hui WK
    Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular ectopy.
    Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
    J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
    [No Abstract]   [Full Text] [Related]  

  • 17. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias.
    Giardina EG
    Ann N Y Acad Sci; 1984; 432():177-88. PubMed ID: 6084435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of antiarrhythmic drugs. Part 1: Lidocaine and procainamide.
    Levitt B; Borer JS; Sarapa A
    Cardiovasc Nurs; 1974; 10(5):23-6. PubMed ID: 4498548
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of procainamide infusions.
    Lima JJ; Goldfarb AL; Conti DR; Golden LH; Bascomb BL; Benedetti GM; Jusko WJ
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.